Organigram Global (STU:0OG) Cyclically Adjusted Revenue per Share: €1.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:0OG Organigram Global Inc STU:0OG
60 GF Score
Price €0.76
GF Value €1.55
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Organigram Global Cyclically Adjusted Revenue per Share?

Organigram Global STU:0OG -1.04% 60 Cyclically Adjusted Revenue per Share is €1.00 as of Mar. 2026. GuruFocus rates STU:0OG with a GF Score™ of 60/100 and a GF Value™ of €1.55 (Possible Value Trap). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Organigram Global's adjusted revenue per share for the three months ended in Mar. 2026 was €0.287. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €1.00 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Organigram Global's average Cyclically Adjusted Revenue Growth Rate was 15.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 16.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Organigram Global was 16.70% per year. The lowest was 16.70% per year. And the median was 16.70% per year.

As of today (2026-07-16), Organigram Global's current stock price is €0.763. Organigram Global's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €1.00. Organigram Global's Cyclically Adjusted PS Ratio of today is 0.76.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Organigram Global was 23.70. The lowest was 0.75. And the median was 1.84.


Organigram Global  (STU:0OG) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Organigram Global's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.763/1.00
=0.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Organigram Global was 23.70. The lowest was 0.75. And the median was 1.84.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Organigram Global Cyclically Adjusted Revenue per Share Related Terms


Organigram Global Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Organigram Global's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Organigram Global Cyclically Adjusted Revenue per Share Chart

Organigram Global Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Sep24 Sep25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.66 0.84 0.88 0.96

Organigram Global Quarterly Data
Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 0.91 0.96 0.96 1.00

STU:0OG vs ZTS, UTHR: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Organigram Global's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organigram Global Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organigram Global's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Organigram Global's Cyclically Adjusted PS Ratio falls into.


STU:0OG
60GF Score
Organigram Global Inc STU:0OG
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Organigram Global Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Organigram Global's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.287/132.2623*132.2623
=0.287

Current CPI (Mar. 2026) = 132.2623.

Organigram Global Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201602 0.066 100.421 0.087
201605 0.088 101.765 0.114
201608 0.074 101.686 0.096
201611 0.071 101.607 0.092
201702 -0.017 102.476 -0.022
201705 0.050 103.108 0.064
201708 0.047 103.108 0.060
201711 0.061 103.740 0.078
201802 0.066 104.688 0.083
201805 0.066 105.399 0.083
201808 0.065 106.031 0.081
201811 0.220 105.478 0.276
201902 0.519 106.268 0.646
201905 0.415 107.927 0.509
201908 0.262 108.085 0.321
201911 0.427 107.769 0.524
202002 0.389 108.559 0.474
202005 0.268 107.532 0.330
202008 0.253 108.243 0.309
202011 0.246 108.796 0.299
202102 0.164 109.745 0.198
202105 0.192 111.404 0.228
202108 0.224 112.668 0.263
202111 0.260 113.932 0.302
202202 0.284 115.986 0.324
202205 0.358 120.016 0.395
202208 0.443 120.569 0.486
202211 0.403 121.675 0.438
202302 0.352 122.070 0.381
202305 0.277 124.045 0.295
202312 0.307 125.072 0.325
202403 0.281 126.258 0.294
202406 0.257 127.522 0.267
202409 0.428 127.285 0.445
202412 0.252 127.364 0.262
202503 0.317 129.181 0.325
202506 0.335 129.892 0.341
202509 0.370 130.287 0.376
202512 0.288 130.366 0.292
202603 0.287 132.262 0.287

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €1.00 mean?
Organigram Global (STU:0OG) has a Cyclically Adjusted Revenue per Share of €1.00 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Organigram Global and its competitors.
Is Organigram Global's Cyclically Adjusted Revenue per Share too high?
Organigram Global's current Cyclically Adjusted Revenue per Share is €1.00. Overall, Organigram Global has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Organigram Global's Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
Organigram Global's Cyclically Adjusted Revenue per Share of €1.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Organigram Global and its competitors. Organigram Global's current Cyclically Adjusted Revenue per Share is €1.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organigram Global stock overvalued right now?
Based on GuruFocus' analysis, Organigram Global (STU:0OG) is currently considered Possible Value Trap. The stock's GF Value™ is €1.55, compared to a current price of €0.76 — trading 50.8% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €1.00. Organigram Global's overall GF Score™ is 60/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Organigram Global (STU:0OG), the current Cyclically Adjusted Revenue per Share is €1.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Organigram Global (STU:0OG) Overvalued in 2026?

Based on GuruFocus' analysis, Organigram Global stock appears to be undervalued. The current stock price of €0.76 is trading 50.8% below its estimated GF Value™ of €1.55. GuruFocus considers Organigram Global to be Possible Value Trap.

Key valuation signals for STU:0OG:

  • Cyclically Adjusted Revenue per Share: €1.00
  • GF Value™: €1.55 vs. price of €0.76 (50.8% below fair value)
  • GF Score™: 60/100 with 1 warning sign

No single metric tells the full story. See the STU:0OG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Organigram Global Business Description

Other Exchanges OGI:USAOGI:Canada
Address 145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
60GF Score

Get the complete analysis for STU:0OG

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.76
Price
€1.55
GF Value